2013
Diagnostic discrepancies between second-opinion and referring pathology reports of neuroendocrine tumors.
Lin H, Longacre T, Khandelwal V, Balise R, Kunz P. Diagnostic discrepancies between second-opinion and referring pathology reports of neuroendocrine tumors. Journal Of Clinical Oncology 2013, 31: e15011-e15011. DOI: 10.1200/jco.2013.31.15_suppl.e15011.Peer-Reviewed Original ResearchNeuroendocrine tumorsPathology reportsMitotic indexHistologic classification schemeStanford University HospitalMajority of casesHistological diagnosisUniversity HospitalAcademic hospitalTreatment planDiagnostic discrepanciesClinical diagnosisKi67Improved reportingNET casesHistological descriptionReporting guidelinesHospitalPathology expertsTumorsRelevant differencesDiagnosisReportFuture studiesGuidelines
2012
A renaissance in therapeutic options for pancreatic neuroendocrine tumors.
Kunz PL. A renaissance in therapeutic options for pancreatic neuroendocrine tumors. American Society Of Clinical Oncology Educational Book 2012, 271-4. PMID: 24451747, DOI: 10.14694/edbook_am.2012.32.136.Peer-Reviewed Original ResearchProgression-free survivalPancreatic neuroendocrine tumorsNeuroendocrine tumorsTherapeutic optionsRandomized placebo-controlled studyPlacebo-controlled studyNovel therapeutic optionsChemotherapy backboneLocoregional diseaseAdvanced diseaseBiologic therapySurgical resectionSomatostatin analoguesClinical trialsDrug AdministrationU.S. FoodAntiproliferative agentsTumorsDiseaseFuture studiesResectionEverolimusSunitinibPatientsOptions